026 Stem Cell Based-Therapy Using the Chitosan-Phosphorycholine Biopolymer
Kim Tardif(Montreal Heart Institute), Jean-François Tanguay(Montreal Heart Institute), Sayaka Toita(Université de Montréal), Françoise M. Winnik(University of Helsinki), Isabelle Cloutier(Montreal Heart Institute)
Cited by 0
Related Papers
Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes
|New England Journal of Medicine|2013|651
Effect of Detecting and Isolating <i>Clostridium difficile</i> Carriers at Hospital Admission on the Incidence of <i>C difficile</i> Infections
|JAMA Internal Medicine|2016|213
Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum.
|The EMBO Journal|1996|143
Improved Function and Myocardial Repair of Infarcted Heart by Intracoronary Injection of Mesenchymal Stem Cell-Derived Growth Factors
|Journal of Cardiovascular Translational Research|2010|109
Subsets of HLA-DR1 Molecules Defined by SEB and TSST-1 Binding
|Science|1994|88